3D Model of Human Mesothelioma to Study Immunotoxin Therapy
Author Information
Author(s): Xiang Xinran, Phung Yen, Feng Mingqian, Nagashima Kunio, Zhang Jingli, Broaddus V. Courtney, Hassan Raffit, FitzGerald David, Ho Mitchell
Primary Institution: Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America
Hypothesis
How does the tumor microenvironment affect the penetration and killing activity of the immunotoxin SS1P in mesothelioma?
Conclusion
The study found that SS1P was significantly less effective in killing mesothelioma cells grown as spheroids compared to those grown as monolayers due to poor penetration.
Supporting Evidence
- Spheroids were at least 100 times less affected by SS1P compared to monolayers.
- Fluorescence microscopy showed limited penetration of SS1P within spheroids after 4 hours.
- E-Cadherin expression was significantly increased in spheroids compared to monolayers.
Takeaway
Researchers created a 3D model of mesothelioma to see how well a cancer drug can get inside and kill the cancer cells. They found that the drug couldn't get in very well, so it didn't work as effectively.
Methodology
The study used a 3D spheroid model of human mesothelioma cells to assess the penetration and efficacy of the immunotoxin SS1P.
Limitations
The study primarily focused on a specific cell line and may not fully represent the complexity of all mesothelioma tumors.
Participant Demographics
The study involved human mesothelioma cell lines and primary cell lines from patients.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website